Free Trial

Arteris (NASDAQ:AIP) Major Shareholder Sells $653,500.00 in Stock

Arteris logo with Computer and Technology background

Key Points

  • Bayview Legacy, LLC, a major shareholder of Arteris, sold 50,000 shares of the company for a total of $653,500 on October 8th, reducing their ownership by 0.51%.
  • Arteris shares are currently trading at $12.39, having experienced a decline recently, while the company's market capitalization stands at approximately $528.43 million.
  • Analysts have mixed ratings on Arteris, with TD Cowen upgrading its price target to $15.00 and maintaining a "buy" rating, while Weiss Ratings restated a "sell" rating.
  • MarketBeat previews top five stocks to own in November.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) major shareholder Bayview Legacy, Llc sold 50,000 shares of the company's stock in a transaction on Wednesday, October 8th. The shares were sold at an average price of $13.07, for a total transaction of $653,500.00. Following the sale, the insider owned 9,689,071 shares of the company's stock, valued at $126,636,157.97. The trade was a 0.51% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Large shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.

Bayview Legacy, Llc also recently made the following trade(s):

  • On Monday, October 6th, Bayview Legacy, Llc sold 100,000 shares of Arteris stock. The shares were sold at an average price of $13.10, for a total transaction of $1,310,000.00.
  • On Tuesday, August 5th, Bayview Legacy, Llc sold 50,000 shares of Arteris stock. The shares were sold at an average price of $13.12, for a total transaction of $656,000.00.

Arteris Price Performance

Shares of Arteris stock traded down $0.72 on Friday, hitting $12.39. 912,434 shares of the company's stock traded hands, compared to its average volume of 573,658. The firm's 50-day moving average price is $9.91 and its two-hundred day moving average price is $8.57. The stock has a market capitalization of $528.43 million, a PE ratio of -15.11 and a beta of 1.45. Arteris, Inc. has a one year low of $5.46 and a one year high of $14.58.

Arteris (NASDAQ:AIP - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, meeting analysts' consensus estimates of ($0.11). Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. The business had revenue of $16.50 million during the quarter, compared to analysts' expectations of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Analysts Set New Price Targets

AIP has been the subject of a number of recent analyst reports. Weiss Ratings restated a "sell (d-)" rating on shares of Arteris in a research report on Wednesday. TD Cowen increased their price objective on shares of Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Finally, Wall Street Zen upgraded shares of Arteris from a "sell" rating to a "hold" rating in a research note on Monday, September 15th. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $15.00.

Get Our Latest Analysis on Arteris

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Raymond James Financial Inc. bought a new position in Arteris in the 2nd quarter valued at about $32,000. CWM LLC raised its holdings in Arteris by 4,810.1% in the 1st quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after acquiring an additional 10,005 shares during the period. Cambridge Investment Research Advisors Inc. bought a new position in Arteris in the 1st quarter valued at about $95,000. Savant Capital LLC bought a new position in Arteris in the 2nd quarter valued at about $97,000. Finally, Kapitalo Investimentos Ltda bought a new position in Arteris in the 2nd quarter valued at about $104,000. 64.36% of the stock is owned by institutional investors.

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Stories

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.